Automated Antimicrobial Susceptibility Testing Market - Trend & Share Analysis (2024-2032)

Automated Antimicrobial Susceptibility Testing Market Synopsis:

Automated Antimicrobial Susceptibility Testing Market Size Was Valued at USD 4.42 Billion in 2023, and is Projected to Reach USD 7.04 Billion by 2032, Growing at a CAGR of 5.3 % From 2024-2032.

Automated AST Market is defined based on the technologies used to measure the resistances of antibiotics and other antimicrobial agents to specified microorganisms. Present goals of computerized AST are to help identify an appropriate antimicrobial regimen in patients with bacterial, viral and fungal infections in microbiology laboratories. These systems take lesser time than traditional methods, provide accurate antibiotic susceptibility data, reduce work load, improve a patient’s health and reduce antibiotic resistance through apposite actions.

At the present time, the Automated Antimicrobial Susceptibility Testing Market is growing at a very high rate primarily due to factors such as a rising prevalence of infectious diseases, inapt use of antibiotics, and high incidents of AMR. This has made AMR to become one of the major causes of death globally, because pathogens combine to develop resistances to normal treatment methods thus renders the antibiotics ineffective. The problem is solved using automated AST systems, because testing of pathogen susceptibility results is made faster and more reliable to inform the right antimicrobials to prescribe the patient. Moreover, adaptation of new higher through-put automated stomatitis systems and incorporation of the systems with LIS are making the relativity safer AST more approachable to diagnose infection diseases in healthcare centers. With such factors and the support from the public health organizations, suitable environments have been created for automating AST Systems in hospitals and commercial laboratories all over the world.

This is due to the ever-rising emphasis that different governments and healthcare organizations are placing in the fight against AMR, as a result there is rapidly increasing demand for the automation of AST. AST systems are also being demanded by many regulatory authorities in most areas for its clinical use with an aim of safeguarding the status of patients and trying to contain their exposure to infections from resistant organisms. However, HAIs today have normalized in the healthcare centers and there is a rising need to ensure that there is real-time data of AMR through automated AST systems used in the infection management. Despite such constraints as high entry barriers, high initial costs, and technological expertise; the overall trends depict a likely improvement owing to crescendo patient-centred urgent diagnostics to get the correct treatment regimen and antibiotic stewardship program.

Automated Antimicrobial Susceptibility Testing Market Trend Analysis:

Shift toward high-throughput AST Systems

• One of the trends at the moment being witnessed in the Automated AST Market is the shift to the high throughput AST systems that have capabilities of analyzing large volumes of samples. There also have been designed high through put systems to match up to the degree of automation necessary requirement in the hospital laboratories where rapid diagnostics techniques are almost in demand and can handle large number of samples at once. These system’s major purpose of having a complex automation especially to help save time in test delivery and also reducing paperwork hence helping the clinician to reach a decision faster than if he or she were to do it independently. One of the benefits of AST can be appreciated most in settings of large health care facilities and commercial laboratories, where large number of microbial samples are processed and accurate and timely information on the behaviour of microbes to an antimicrobial agent is important in containment of outbreak and spread of resistant strains. As more analytical laboratories seek more effective methods of increasing throughput and increasing the rate of diagnosis, Hi throughput AST systems are therefore being implemented and considered to be an emerging trend in AST systems.

Growing Demand for AST Solutions in Emerging Markets

• The global Automated Antimicrobial Susceptibility Testing Market has the promise of significant growth for the new generation markets. It is clear that new investment flowing to Asia-Pacific, Latin American, and some parts of Africa health-care systems and for controlling infectious diseases is apparent because rising demand for managing the higher burden of infectious diseases, new government focus on public health. Due to high levels of AMR in these areas, programmes require policies that will ensure efficient and cheap AST for recommending correct treatment in situations where control of disease is compromised. Furthermore, the conversion of those areas with better access to healthcare and establishment of intricate and modish laboratories enhances the demand of elevated and enhanced diagnosis equipment such as automated AST system. The following are the identified opportunities that could help to capture present and future demand in the global AST market.

Automated Antimicrobial Susceptibility Testing Market Segment Analysis:

Automated Antimicrobial Susceptibility Testing Market is Segmented on the basis of Product Type, Application, End User, and Region

By Product Type, Consumables segment is expected to dominate the market during the forecast period

• Automated AST Market segmented by component Consume segment took the largest part of the whole share in the forecasted period. The products which are needed to be replaced more often in shorter cycles make consumables, be it reagents, panels, or the test kits used in the AST systems to give manufacturers a consistent perpetual stream of earnings. There is emergence of various new infectious diseases and there is awareness of AMR which in turn leads to increased number of AST tests worldwide hence the consumables. These products are almost essential for maintaining accuracy and constancy in the susceptibility testing with the newer prototypes in consumables which not only have better and updated microbial identification but have built further on these enhancements, on new susceptibility panels. Even as the broader scale AST systems are gradually being implemented in the healthcare facility and research laboratory for general operations the consumables segment is expected to dominate the market to a large extent

By Application, Antibacterial segment expected to held the largest share

• Consequently, the antibacterial segment is believed to hold the largest share of the Automated AST market based on the type. This segment relates to the extent to which bacterial pathogens are resistant to those antibiotics that are usually used to treat such infections. Bacterial infections are on the rise excluding the question of antibiotic resistance and such testing is now important and necessary to hasten. This way the automated AST systems match the right antibiotics treatment in the shortest time hence reducing bacterial infections and over use of antibiotics. Infections due to AR organisms such as MRSA and drug-resistant TB are still a reality and need for an antibacterial AST is most likely going to continue hence establishing this segments dominance.

Automated Antimicrobial Susceptibility Testing Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• In the forecast period, North America is expected to dominate the Automated AST Market as there are huge developments in the healthcare sectors, intensive usage of diagnostics, and enhanced funding and measures against AMR. The United States has been more active in combating AMR especially when government bodies and other health institutions have increased their efforts to embrace the use of automated AST systems in ordering drugs particularly antibiotics. Health care departments of the FDA and CDC have applied Aggressive measures in the relationship between antimicrobial drugs and diagnostics that encourage the implementation of AST systems to the clinical and commercial laboratories.
• Canada is another large North American AST market because the country has given a lot of importance to the use of antibiotics and infection control. AMR is restrained through public health intercessory and government-financed programs through appropriate diagnostic and therapeutic management planning making automated AST a swiftly growing specialty. Because HAI rates are still elevated and definitive diagnostics are still required, the U.S. and Canada will likely continue to drive the industry forward.

Active Key Players in the Automated Antimicrobial Susceptibility Testing Market:

• Accelerate Diagnostics (USA)
• Alifax S.r.l. (Italy)
• Beckman Coulter, Inc. (USA)
• Becton, Dickinson and Company (USA)
• bioMérieux SA (France)
• Bruker Corporation (USA)
• Danaher Corporation (USA)
• Eiken Chemical Co., Ltd. (Japan)
• HiMedia Laboratories (India)
• Merck KGaA (Germany)
• OpGen, Inc. (USA)
• Roche Diagnostics (Switzerland)
• Thermo Fisher Scientific, Inc. (USA)
• Trinity Biotech plc (Ireland)
• Zhuhai DL Biotech Co., Ltd. (China), and Other Active Players.